Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies.

Causaly

Domain Not Resolving

DNSSEC

Google Maps

Mobile Non Scaleable Content

reCAPTCHA

Cloudflare CDN

jsDelivr

Cloudflare JS

Gravatar Profiles

Facebook Sharer

Co-Founder, CTO

Artur Saudabayev

VP Sales EMEA

Andrew Dalton

VP, Sales - North America

Bryan Tucker

VP People

Dan Atkinson

Vice President Marketing

Katleen Richardson

VP Finance

Ryan Collett

Engineering

Dimitrios Michalakos

Head of Financial Control

Galina Kuts

Marketing and Product

Jamie Heekyung Chung

Human Resources

Maria Loufardaki

Carlos Gonzalez- Cadenas

George Tziralis

Yiannis Kiachopoulos

CEO and Co-Founder

Co-Founder and CTO

Aris Goudouras

Software Engineer

Nikos Kalogridis

Senior Software Engineer

Europe Artificial Intelligence (AI) Companies (Top 10K)

United Kingdom Artificial Intelligence (AI) Companies

Artificial Intelligence (AI) Companies With Fewer Than 1000 Employees (Top 10K)

Europe, Middle East, and Africa (EMEA) Companies With More Than 50 Employees (Top 10K)

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine. It amplifies human cognitive abilities to expand the boundaries of discovery toward making the best decisions in biomedicine.

ICONIQ Growth

Series B - Causaly

Venture Round - Causaly

Index Ventures

Series A - Causaly

Pentech Ventures

Marathon Venture Capital

Seed Round - Causaly

London

England

United Kingdom

Europe

10 Series A+ AI Startups from CEE with Unicorn Potential Pt. 2

Healthtech in 2023

RapidAI Raises $75M To Help Diagnose Strokes

Big Tech Companies Joining Competitive AI Drug ...

£46m boost for AI MedTech Causaly

Causaly raises $60m Series B to give scientists instant access to 'all of biology'

Causaly, an AI platform for drug discovery and biomedical research, raises $60M

Causaly Raises $60M in Series B Funding

A platform that accelerates drug discovery projects by enabling researchers to find, analyze, and connect evidence from biomedical documents.

Allows users to identify potential mediators of target-disease effects and generate hypotheses for drug discovery.

Enables users to refine search results by target class, providing a granular view of targets for specific diseases.

United States

North America

Canada

Greece

Sweden

HTML5

Google Tag Manager

Lead Flows

Google Analytics

Google Compute Engine

Wordpress

Adobe Fonts

Vimeo

Wistia

Facebook Comments

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 18, 2024 2:12 PM	4a4c15dc
crunchbase profile	general	Nov 19, 2024 10:10 AM	1c46eafb
li profile	general
translate crunchbase fundingrounds	general	Nov 19, 2024 10:43 AM	faf98cdc
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:CAUSALY

Causaly